No complaint of overcharging against any doctor: Govt

No complaint of overcharging against any doctor: Govt
Spread the love

Srinagar: Not a single complaint has been received against any doctor for overcharging patients, the state government informed the court Wednesday.
Additional Advocate General Muhammad Iqbal Dar informed the court that no such compliant had been received by the Health department against any doctor.
On the previous hearing in a Public Interest Litigation linked to the matter, the division bench of Chief Justice Baddar Durrez Ahmad and Justice Ali Muhammad Magrey had directed the government to come up with the list of complaints received against doctors for overcharging patients.
The bench remarked that public should be made aware of the issue and a grievance redress cell should be operated where general public can put up their issues.
The court was also informed that government has given wide publicity to the circular issued by National Pharmaceutical Pricing Authority (NPPA) under union ministry of chemicals and fertilizers whereby ceiling prices of “coronary stents” were fixed, in seven newspapers.
The union health ministry in its affidavit filed through its Assistant Solicitor General Tahir Shamsi informed the court that it has communicated to all the hospitals about the NPPA circular.
The court asked Shamsi to file affidavit on behalf of union chemicals and fertilizer ministry about the prices of drugs within four weeks.
On previous hearing Shamsi informed the court that NPPA in its meeting on 13 February 2017 after considering all available information and relevant data for price fixation of coronary stents has fixed ceiling prices of coronary stents. NPPA has fixed Rs 7260 as ceiling price for Bare Metal Stent while as the Rs 29600 has been fixed for Drug Eluting Stents (DES) including metallic DES and bioresorbable vascular scaffold (BVS)/ biodegradable stents.
On October 26, 2016, the High Court took a suo-moto cognizance of the news reports on medical corruption and treated the articles as Public Interest Litigation.

Leave a Reply

Your email address will not be published.